The trajectory of companies tied to iconic drugs like Viagra presents a nuanced investment picture. While the initial boom of copyright, fueled by Viagra's extraordinary popularity, generated substantial wealth , the expiry in key regions has introduced considerable risk . Investors are now facing the effect of generic competition , shrinking incom